RXRX vs MNKD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

RXRX

44.1
AI Score
VS
RXRX Wins

MNKD

36.9
AI Score

Investment Advisor Scores

RXRX

44score
Recommendation
HOLD

MNKD

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX MNKD Winner
Forward P/E 0 30.303 Tie
PEG Ratio 0 4.3866 Tie
Revenue Growth -60.1% 42.9% MNKD
Earnings Growth 0.0% -34.9% RXRX
Tradestie Score 44.1/100 36.9/100 RXRX
Profit Margin 0.0% -11.1% RXRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL RXRX

Relative Price Performance (Last 90 Days)

RXRX 1M: -2.7% · 3M: +1.6% MNKD 1M: -2.6% · 3M: +0.0%

Current Technical Phase

RXRX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 46

RSI (14): 45.6 · Price: $3.20

MNKD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.7 · Price: $3.75

Fundamentals Snapshot

Metric RXRX MNKD
Market Cap
Forward P/E -3.6 29.4
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 0.4%
Gross Margin -7.2% 0.8%
Operating Margin -17.6% 0.0%
EPS -0.98 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.